Research and Development

Showing 15 posts of 9618 posts found.

chemo-web

Untested cancer drug suspected cause of three deaths at German alternative medicine centre

August 17, 2016 Research and Development 3-Bromopyruvate, Cancer, Germany, alternative medicine, patient deaths

The deaths of three patients at an alternative medicine clinic in Germany have prompted suspicion of a clinically untested cancer …
shutterstock_141299494

GSK, Roche and Novo back $86 million immuno-oncology startup

August 17, 2016 Research and Development CD47, Cancer, GSK, Novo, Roche, Tioma, oncology

Brisbane-based venture-stage biopharmaceutical company Tioma Therapeutics has announced it has raised $86 million in Series A venture financing for its …
praluent_75mg_pen_box_hr

Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds

August 17, 2016 Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent

A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …
landing-hero-images1

ViiV Healthcare launches Phase III trial for combo HIV treatment

August 16, 2016 Research and Development Dolutegravir, HIV, Tivicay, ViiV Healthcare, epivir, lamivudine, phase III

The Pfizer/GSK spin off ViiV Healthcare has announced the beginning of a Phase III evaluating Tivicay (dolutegravir) and Epivir (lamivudine) …
msd

MSD to cut 148 jobs at Pennsylvania plant

August 16, 2016 Manufacturing and Production, Research and Development MSD, job cuts, zontivity

MSD is due to cut 148 jobs at its North Wales, Pennsylvania campus effective September 12, according to the company’s …

Ashfield launches Global Impact On Society Initiative

August 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016 Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …
kalydeco

Vertex stumbles in Phase III cystic fibrosis trials

August 16, 2016 Manufacturing and Production, Research and Development Vertex, cystic fibrosis, phase III

Vertex Pharmaceuticals has provided an update on its ongoing Phase III trials investigating VX-661 in combination with Kalydeco (ivacaftor) in …
ucb_logo_pole2

US court rules in favour of UCB in patent dispute, shares jump

August 16, 2016 Manufacturing and Production, Research and Development, Sales and Marketing UCB, lacosamide, patent, vimpat

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one …

FDA finds drug class at centre of French trial tragedy do not pose similar safety risks

August 15, 2016 Manufacturing and Production, Research and Development Bial, Biotrial, FDA, faah, rennes

The US Food and Drug Administration (FDA) has issued a statement following the results of their investigation into the recent …
eu_flag

UK Government commits to funding EU research projects after Brexit

August 15, 2016 Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
shutterstock_76507048

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016 Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …
vaccination

Sanofi launches dengue immunisation program in Brazil

August 15, 2016 Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
abbvie_0

Study shows promise for Venclexta in acute myelogenous leukaemia

August 12, 2016 Research and Development, Sales and Marketing AbbVie, Genentech, Roche, Venclexta, venetoclax

A study published in Cancer Discovery, the journal of the American Association for Cancer Research, suggests that Vencletxa (venetoclax) is …
The Gateway to Local Adoption Series

Latest content